Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;20(2):348-354.
doi: 10.1111/ajt.15680. Epub 2019 Nov 28.

Outstanding questions in transplantation: Tolerance

Affiliations
Free article
Review

Outstanding questions in transplantation: Tolerance

Joseph R Leventhal et al. Am J Transplant. 2020 Feb.
Free article

Abstract

In 2017, the American Society of Transplantation (AST) launched the Outstanding Questions in Transplantation Research forum to stimulate a community-wide discussion of how the field is evolving and to help identify areas where a better dialogue between clinicians and researchers could result in great advancements. Tolerance emerged as a topic of great interest to the AST community. This minireview provides an overview of clinical transplantation tolerance. Historical background followed by a review of the current status of attempts to establish tolerance in the clinic, highlighting the dynamic online discussion surrounding this important topic from the AST Transplantation Research forum, is provided.

Keywords: immunosuppression/immune modulation; stem cells; tolerance: chimerism; tolerance: clinical; tolerance: mechanisms; translational research/science.

PubMed Disclaimer

References

REFERENCES

    1. Helderman JH, Van Buren DH, Amend WJ Jr, Pirsch JD. Chronic immunosuppression of the renal transplant patient. J Am Soc Nephrol. 1994;4(8 Suppl):S2-S9.
    1. Gaston RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis. 2001;38(6 Suppl 6):S25-S35.
    1. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. Hyperlipidemia and transplantation: etiologic factors and therapy. J Am Soc Nephrol. 1992;2(12 Suppl):S238-S242.
    1. Shaw LM, Kaplan B, Kaufman D. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin Chem. 1996;42(8 Pt 2):1316-1321.
    1. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 2006;21(9):2630-2636.

MeSH terms

LinkOut - more resources